subscribeSubscribe
IPAB stays revocation of Novartis’ patent on anti-cancer drug Ceritinib

IPAB stays revocation of Novartis’ patent on anti-cancer drug Ceritinib
PHARMABIZ
12 Aug 2020
Share Share
NICE final guidance backs Pfizer`s Lorviqua

NICE final guidance backs Pfizer`s Lorviqua
Selina McKee PHARMA TIMES
13 May 2020
Share Share
Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts

Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts
Angus Liu FIERCE PHARMA
11 Oct 2018
Share Share
Preliminary NICE ‘no’ for Takeda’s Alunbrig

Preliminary NICE ‘no’ for Takeda’s Alunbrig
Selina McKee PHARMA TIMES
03 Oct 2018
Share Share
Takeda`s Alunbrig trounces Pfizer drug in bid for earlier ALK lung cancer use

Takeda`s Alunbrig trounces Pfizer drug in bid for earlier ALK lung cancer use
Carly Helfand FIERCE PHARMA
26 Sep 2018
Share Share
Bristol-Myers to sell Opdivo in China at half-price: report

Bristol-Myers to sell Opdivo in China at half-price: report
Angus Liu FIERCE PHARMA
22 Aug 2018
Share Share
Pfizer files third-gen ALK inhibitor for lung cancer

Pfizer files third-gen ALK inhibitor for lung cancer
Phil Taylor PMLIVE
14 Feb 2018
Share Share
First-line use of lung cancer drug Zykadia gets NHS nod

First-line use of lung cancer drug Zykadia gets NHS nod
Selina McKee PHARMA TIMES
25 Jan 2018
Share Share
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report

Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Angus Liu FIERCE PHARMA
06 Jan 2018
Share Share
Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China

Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China
Amber Tong END POINTS
03 Jan 2018
Share Share